Login / Signup

Lipoplexes and polyplexes as nucleic acids delivery nanosystems: The current state and future considerations.

Bruno CostaBeatriz BoueriClaudia OliveiraIsabel SilveiraAntónio José Ribeiro
Published in: Expert opinion on drug delivery (2022)
experiments. Clinical practice would benefit from safer non-viral vectors, particularly when avoiding patients' immune responses and toxicity, which is of major concern.
Keyphrases
  • immune response
  • clinical practice
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • oxidative stress
  • dendritic cells
  • current status
  • toll like receptor
  • patient reported outcomes
  • inflammatory response